MedTrace Logo

Algology in Oncology Osteopathic Support (ALGOS)

NCT05726929 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-02-18

No results posted yet for this study

Summary

The aim of the study is to evaluate the Impact of add-on osteopathic treatment in the algological course of patients treated for breast cancer : Randomized Controlled Trial.

Conditions

Interventions

OTHER

Osteopathic treatment

Osteopathic Manual Treatment

OTHER

Capsaicin QUTENZA Patch (TAU)

Capsaicin QUTENZA Patch is the treatment as usual (TAU) delivered in the medical algology service

Sponsors & Collaborators

  • Institut Claudius Regaud

    collaborator OTHER

  • Institut Toulousain d'Ostéopathie

    lead OTHER

Principal Investigators

  • Loïc TREFFEL, PhD · Institut Toulousain d'Ostéopathie

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2024-12-08
Completion
2024-12-08

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05726929 on ClinicalTrials.gov